EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED: O HKD
| Exchange | Code | Listed | Last trade | Delisted | |
|---|---|---|---|---|---|
| HK Main | 00858 | 1999-03-10 |
Note: There figures are from the counter used for "parallel trading" of shares represented by old certificates, in parallel with trading on the main counter (or stock code) after a split, consolidation or change of board lot size. It's an archaic practice because we have had electronic settlement with a central counterparty by book-entry since 1993, so in reality no certificates change hands. It was due to be abolished on 3-Nov-08, but abolition has been delayed indefinitely. S=1 if suspended.
| Trade date | S | Close | Bid | Ask | Low | High | Volume | Turnover $ | VWAP |
|---|---|---|---|---|---|---|---|---|---|
| 2000-03-23 | 0 | 0.192 | 0.190 | - | - | - | 0 | 0 | - |
| 2000-03-22 | 0 | 0.192 | - | - | - | - | 0 | 0 | - |
| 2000-03-21 | 0 | 0.192 | - | - | - | - | 0 | 0 | - |
| 2000-03-20 | 0 | 0.192 | 0.188 | - | - | - | 0 | 0 | - |
| 2000-03-17 | 0 | 0.192 | 0.188 | - | - | - | 0 | 0 | - |
| 2000-03-16 | 0 | 0.192 | - | - | - | - | 0 | 0 | - |
| 2000-03-15 | 0 | 0.192 | - | - | - | - | 0 | 0 | - |
| 2000-03-14 | 0 | 0.192 | - | 0.200 | - | - | 0 | 0 | - |
| 2000-03-13 | 0 | 0.192 | 0.185 | - | - | - | 0 | 0 | - |
| 2000-03-10 | 0 | 0.192 | 0.188 | 0.195 | - | - | 0 | 0 | - |
| 2000-03-09 | 0 | 0.192 | 0.189 | - | 0.192 | 0.192 | 200,000 | 38,400 | 0.1920 |
| 2000-03-08 | 0 | 0.196 | 0.195 | - | 0.196 | 0.196 | 120,000 | 23,520 | 0.1960 |
| 2000-03-07 | 0 | 0.194 | 0.189 | 0.194 | 0.189 | 0.194 | 480,000 | 91,400 | 0.1904 |
| 2000-03-06 | 0 | 0.193 | 0.193 | 0.200 | 0.192 | 0.193 | 300,000 | 57,800 | 0.1927 |
| 2000-03-03 | 0 | 0.200 | 0.193 | 0.200 | 0.193 | 0.200 | 2,160,000 | 418,380 | 0.1937 |
| 2000-03-02 | 0 | 0.194 | 0.194 | 0.200 | 0.192 | 0.204 | 1,860,000 | 372,920 | 0.2005 |
Copyright & disclaimer, Privacy policy
Webb-site.com was originally created by David M Webb MBE
We are committed to maintaining high quality and expanding the database with additional data and insight.